A case control etiologic study of sarcoidosis: Environmental and occupational risk factors

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 12, 2004, Pages 1324-1330

  Newman, Lee S ^a   Rose, Cecile S ^b   Bresnitz, Eddy A ^b   Rossman, Milton D ^b   Barnard, Juliana ^b   Frederick, Margaret ^b   Terrin, Michael L ^b   Weinberger, Steven E ^b   Moller, David R ^b   McLennan, Geoffrey ^b   Hunninghake, Gary ^b   DePalo, Louis ^b   Baughman, Robert P ^b   Iannuzzi, Michael C ^b   Judson, Marc A ^b   Knatterud, Genell L ^b   Thompson, Bruce W ^b   Teirstein, Alvin S ^b   Yeager Jr , Henry ^b   Johns, Carol J ^b   Rabin, David L ^b   Rybicki, Benjamin A ^b   Cherniack, Reuben ^b   more..

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b NONE

Author keywords

Environment; Etiology; Granuloma; Occupation; Risk factors; Sarcoidosis

Indexed keywords

INSECTICIDE;

ANALYSIS OF VARIANCE; ARTICLE; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OCCUPATIONAL EXPOSURE; ODOR; PRIORITY JOURNAL; QUESTIONNAIRE; SARCOIDOSIS; STATISTICAL MODEL; WORK ENVIRONMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OCCUPATIONAL EXPOSURE; RISK FACTORS; SARCOIDOSIS;

EID: 10644294658     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200402-249OC     Document Type: Article

References (99)

1. Rybicki BA, Major M, Popovich JJ, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145:234-241.
2. Bresnitz EA, Strom BL. Epidemiology of sarcoidosis. Epidemiol Rev 1983;5:124-156.
3. Newman LS, Rose CS, Maier LA. Medical progress: sarcoidosis. N Engl J Med 1997;336:1224-1234.
4. American Thoracic Society/European Respiratory Society. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-755.
5. Kucera GP, Rybicki B, Kirkey KL, Coon SW, Major ML, Maliarik M, Iannuzzi MC. Occupational risk factors for sarcoidosis in African-American siblings. Chest 2003;123:1527-1535.
6. Moller DR. Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex? Am J Respir Cell Mol Biol 2002;27:391-395.
7. Vourlekis JS, Sawyer RT, Newman LS. Sarcoidosis: developments in etiology, immunology, and therapeutics. Adv Intern Med 2000;45:209-257.
8. Siltzbach LE. Significance and specificity of the Kveim reaction. Acta Med Scand Suppl 1964;425:74-78.
9. James D. Sarcoidosis and other granulomatous disorders. New York: Marcel Decker, Inc.; 1994.
10. Newman LS. Beryllium disease and sarcoidosis: clinical and laboratory links. Sarcoidosis 1995;12:7-19.
11. Newman LS. Metals that cause sarcoidosis. Semin Respir Infect 1998; 13:212-220.
12. Rose C. Hypersensitivity pneumonitis. In: Harber P, Schenker M, Balmes J, editors. Occupational and environmental respiratory disease. St. Luois: Mosby Year Book, Inc.; 1996. pp. 201-215.
13. Ito Y, Toyoma J, Marikawa S. The production of granulomas in animals and men by a propionibacterium in suspension and Yersinia. In: Williams W, Davies B, editors. Proceedings of the eighth international conference on sarcoidosis and other granulomatous diseases. Cardiff: Alpha Omega Publishing, Ltd; 1980. pp. 121-132.
14. Van Etta L, Filice R, Ferguson R, Gerding D. Corynebacterium egia: a review of 12 cases of human infection. Rev Infect Dis 1983;5:1012-1017.
15. Spapen HD, Segers O, De Wit N, Goossens A, Buydens P, Dierckx R, Somers G. Electron microscopic detection of Whipple's bacillus in sarcoidlike periodic acid-Schiff-negative granulomas. Dig Dis Sci 1989; 34:640-643.
16. Ehlers S, Mielke ME, Hahn H. The mRNA-phenotype of granuloma formation: CD4+ T cell-associated cytokine gene expression during primary murine listeriosis. Immunobiology 1994;191:432-440.
17. Mangiapan G, Hance AJ. Mycobacteria and sarcoidosis: an overview and summary of recent molecular biological data. Sarcoidosis 1995; 12:20-37.
18. Di Alberti L, Piattelli A, Artese L, Favia G, Patel S, Saunders N, Porter SR, Scully CM, Ngui SL, Teo CG. Human herpesvirus 8 variants in sarcoid tissues. Lancet 1997;350:1655-1661.
19. Rose CS, Martyny JW, Newman LS, Milton DK, King TE Jr, Beebe JL, McCammon JB, Hoffman RE, Kreiss K. Lifeguard lung": endemic granulomatous pneumonitis in an indoor swimming pool. Am J Public Health 1998;88:1795-1800.
20. Ishige I, Usui Y, Takemura T, Eishi Y. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 1999;354:120-123.
21. Case records of the Massachusetts General Hospital. Case 27-2000. A 61-year-old with rapidly progressive dyspnea. N Engl J Med 2000; 343:642-649.
22. Alliot C, Barrios M, Brunei M. Sarcoidosis-lymphoma syndrome with alternating outbreaks of the two illnesses. Ann Med Interne (Paris) 2000;151:232-233.
23. Bardinas F, Morera J, Fite E, Plasencia A. Seasonal clustering of sarcoidosis. Lancet 1989;2:455-456.
24. Henke CE, Henke G, Elveback LR, Beard LR, Ballard DJ, Kurland LT. The epidemiology of sarcoidosis in Rochester, Minnesota: A population-based study of incidence and survival. Am J Epidemiol 1986;123: 840-845.
25. Putkonen T, Hannuksela M, Mustakallio KK. Cold season prevalence in the clinical onset of sarcoidosis. Arch Environ Health 1966;12:564-568.
26. Hills SE, Parkes SA, Baker SBdC. Epidemiology of sarcoidosis in the Isle of Man - 2: Evidence for space-time clustering. Thorax 1987;42: 427-430.
27. Parkes SA, Baker SBdC, Bourdillon RE, Murray CRH, Rakshit M. Epidemiology of sarcoidosis in the Isle of Man - 1: A case controlled study. Thorax 1987;42:420-426.
28. Sartwell PE, Edwards LB. Epidemiology of sarcoidosis in the US Navy. Am J Epidemiol 1974;99:250-257.
29. Horwitz O. Geographic epidemiology of sarcoidosis in Denmark. Am Rev Respir Dis 1961;84:130-134.
30. Rybicki BA, Iannuzzi MC, Frederick MM, Thompson BW, Rossman MD, Bresnitz EA, Terrin ML, Moller DR, Barnard J, Baughman RP, et al. Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001;164:2085-2091.
31. McGrath D, Daniil Z, Foley P, du Bois J, Lympany P, Cullinan P, du Bois R. Epidemiology of familial sarcoidosis in the UK. Thorax 2000;55:751-754.
32. Wiman LG. Familial occurrence of sarcoidosis. Scand J Respir Dis Suppl 1972;80:115-119.
33. Brennan NJ, Crean P, Long J, Fitzgerald M. High prevalence of familial sarcoidosis in an Irish population. Thorax 1984;39:14-18.
34. Schurmann M, Lympany PA, Reichel P, Muller-Myhsok B, Wurm K, Schlaak M, Muller-Quernheim J, du Bois RM, Schwinger E. Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med 2000;162:861-864.
35. Bresnitz EA, Stolley PD, Israel HL, Soper K. Possible risk factors for sarcoidosis: a case-control study. Ann NY Acad Sci 1986;465:632-642.
36. Dunner E, Williams JH Jr. Epidemiology of sarcoidosis in the United States. Am Rev Respir Dis 1961;84:163-168.
37. Keller AZ. Hospital, age, racial, occupational, geographical, clinical, and survivorship characteristics in the epidemiology of sarcoidosis. Am J Epidemiol 1971;94:222-230.
38. Kern DG, Neill MA, Wrenn DS, Varone JC. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am Rev Respir Dis 1993;148:974-980.
39. Prezant DJ, Dhala A, Goldstein A, Janus D, Ortiz F, Aldrich TK, Kelly KJ. The incidence, prevalence, and severity of sarcoidosis in New York City firefighters. Chest 1999;116:1183-1193.
40. Parkes SA, Baker SBdC, Bourdillon RE, Murray CRH, Rakshit M, Sarkies JWR, Travers JP, Williams EW. Incidence of sarcoidosis in the Isle of Man. Thorax 1985;40:284-287.
41. Edmondstone WM. Sarcoidosis in nurses: is there an association? Thorax 1988;43:342-343.
42. McDonough C, Gray GC. Risk factors for sarcoidosis hospitalization among US Navy and Marine Corps personnel, 1981 to 1995. Mil Med 2000;165:630-632.
43. Cooch JW. Sarcoidosis in the United States Army, 1952 through 1956. Am Rev Respir Dis 1961;84:103-108.
44. Cummings MM, Dunner E, Williams JH Jr. Epidemiologic and clinical observations in sarcoidosis. Ann Intern Med 1959;50:879-890.
45. Buck AA. Epidemiologic investigations of sarcoidosis: I. Introduction; material and methods. Am J Hyg 1961;74:137-151.
46. Douglas AC. Sarcoidosis in Scotland. Am Rev Respir Dis 1961;84:143-147.
47. Gentry JT, Nitowsky HM, Michael MJ. Studies on the epidemiology of sarcoidosis in the United States: The relationship to soil areas and to urban-rural residence. J Clin Invest 1955;34:1839-1856.
48. Kajdasz DK, Lackland DT, Mohr LC, Judson MA. A current assessment of rurally linked exposures as potential risk factors for sarcoidosis. Ann Epidemiol 2001;11:111-117.
49. Barnard J, Rose CS, Newman LS, Canner M, Terrin ML, Bresnitz EA, Martyny JW, McCammon CS, Rossman MD, Rybicki BA, ACCESS Research Group. Job and industry classifications associated with sarcoidosis in a Case Control Etiologic Study of Sarcoidosis (ACCESS). Am J Respir Crit Care Med 2003;169:A682.
50. Maier LA, Sato H, Nicholson JL, McGrath DS, Silveira L, Lympany P, Welsh KI, duBois RM, Rose CS, Newman LS, et al. Distinct TAP1 and TAP2 polymorphisms are associated with chronic beryllium disease and sarcoidosis. Am J Respir Crit Care Med 2004;169:A217.
51. ACCESS. Design of a case control etiologic study of sarcoidosis (ACCESS). J Clin Epidemiol 1999;52:1173-1186.
52. Judson M, Baughman R, Teirstein A, Terrin M, Yeager HJ, ACCESS Research Group. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:75-86.
53. Maier LA, Newman LS. Beryllium disease. In: Rom WN, editor. Environmental and occupational medicine, 3rd ed. L Philadelphia: Lippincott-Raven Publishers; 1998. pp. 1017-1031.
54. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, et al. Clinical characteristics of patients in a case control study of sarcoidosis. [abstract] Am J Respir Crit Care Med 2001;164:1885-1889.
55. Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc 1978;73:40-46.
56. Baumgartner KB, Samet JM, Coultas DB, Stidley CA, Hunt WC, Colby TV, Waldron JA. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Am J Epidemiol 2000;152:307-315.
57. Ferris BG. Epidemiology standardization project. Am Rev Respir Dis 1978;118:1-12.
58. Breslow N, Day N. Statistical methods in cancer research: Vol. I. The analysis of case control studies. IARC Sci Publ 1980;32:84-119.
59. Merritt JC, Ballard DJ, Checkoway H, Mower P, Grimson R. Ocular sarcoidosis: a case-control study among black patients. Ann NY Acad Sci 1986;465:619-624.
60. Terris M, Chaves AD. An epidemiologic study of sarcoidosis. Am Rev Respir Dis 1966;94:50-55.
61. Buck AA. Epidemiologic investigations of sarcoidosis: IV. Discussion and summary. Am J Hyg 1961;74:189-202.
62. Buck AA. McKusick VA. Epidemiologic investigations of sarcoidosis: III. Serum proteins; syphilis; association with tuberculosis; familial aggregation. Am J Hyg 1961;74:174-188.
63. Buck AA, Sartwell PE. Epidemiologic investigations of sarcoidosis: II. Skin sensitivity and environmental factors. Am J Hyg 1961;74:152-173.
64. Drent M, Bomans PH, Van Suylen RJ, Lamers RJ, Bast A, Wouters EF. Association of man-made mineral fibre exposure and sarcoidlike granulomas. Respir Med 2000;94:815-820.
65. Farber HW, Fairman RP, Glauser FL. Talc granulomatosis: laboratory findings similar to sarcoidosis. Am Rev Respir Dis 1982;125:258-261.
66. Rafnsson V, Ingimarsson O, Hjalmarsson I, Gunnarsdottir H. Association between exposure to crystalline silica and risk of sarcoidosis. Occup Environ Med 1998;55:657-660.
67. Thomeer M, Van Bleyenbergh P, Nemery B, Demedts M. A breathless accountant who blew up balloons. Lancet 1999;354:124.
68. National Institute for Occupational Safety (NIOSH). Sarcoidosis among US Navy and Marine Corps personnel. MMWR 1997;46(23):539-543.
69. Jajosky P. Sarcoidosis diagnoses among US military personnel: trends and ship assignment associations. Am J Prev Med 1998;14:176-183.
70. Rybicki BA, Maliarik MJ, Major M, Popovich J Jr, Iannuzzi MC. Epidemiology, demographics, and genetics of sarcoidosis. Semin Respir Infect 1998;13:166-173.
71. Reich JM, Johnson RE. Incidence of clinically identified sarcoidosis in a northwest United States population. Sarcoidosis Vasc Diffuse Lung Dis 1996;13:173-177.
72. Checkoway H, Pearce N, Crawford-Brown D. Research methods in occupational epidemiology. New York: Oxford University Press; 1989.
73. Kelleher PC, Martyny JW, Mroz MM, Maier LA, Ruttenber AJ, Young DA, Newman LS. Beryllium particulate exposure and disease relations in a beryllium machining plant. J Occup Environ Med 2001;43:238-249.
74. Ortiz C, Hodgson M, McNally D, Storey E. Sarcoidosis and exposure to occupational and environmental agents. In: Johanning E, editor. Bioaerosols, fungi and myotoxins: health effects, assessment, prevention and control. Albany, NY: Eastern New York & Environmental Health Center; 1999.
75. Lewis, TJ. A case of recurrent pneumonia. J Tenn Med Assoc 1991;84: 442-444.
76. Carlson JE, Villaveces JW. Hypersensitivity pneumonitis due to pyrethrum: report of a case. JAMA 1977;237:1718-1719.
77. Rose C. Hypersensitivity pneumonitis. In: Rosenstock L, Cullen MR, editors. Textbook of clinical occupational and environmental medicine. Philadelphia: W.B. Saunders Co.; 1994. pp. 242-248.
78. Favata EA, Neill HM, Yang CS. Emerging microbial diseases of the indoor environment. In: Couturier AJ, editor. Occupational and environmental infectious diseases. Beverly Farms, MA: OEM Press; 2000. pp. 697-716.
79. Andersson MA, Nikulin M, Koljalg U, Andersson MC, Rainey F, Reijula K, Hintikka EL, Salkinoja-Salonen M. Bacteria, molds, and toxins in water-damaged building materials. Appl Environ Microbiol 1997;63: 387-393.
80. Verhoeff AP, van Wijnen JH, Brunekreef B, Fischer P, van Reenen-Hoekstra ES, Samson RA. Presence of viable mould propagules in indoor air in relation to house damp and outdoor air. Allergy 1992; 47:83-91.
81. Finnegan MJ, Pickering C, Burge PS. The sick building syndrome: prevalence studies. BMJ 1984;289:1573-1575.
82. Mendell MJ, Smith AH. Consistent pattern of elevated symptoms in air-conditioned office buildings: a reanalysis of epidemiologic studies. Am J Public Health 1990;80:1193-1199.
83. Rose C, Robins T, Harkaway P. Biopsy-confirmed hypersensitivity pneumonitis in automobile production workers exposed to metal working fluids - Michigan, 1994-1995. MMWR 1996;45(28):606-609.
84. Drent M, Kessels BL, Bomans PH, Wagenaar SS, Henderson RF. Sarcoidlike lung granulomatosis induced by glass fibre exposure. Sarcoidosis Vasc Diffuse Lung Dis 2000;17:86-87.
85. Selman M. Hypersensitivity pneumonitis. In: Schwarz MI, King TE, Jr., editors. Interstitial lung disease. London: B.C. Decker, Inc.; 1998. pp. 393-422.
86. Douglas JG, Middleton WG, Gaddie J, Petrie GR, Choo-Kang YF, Prescott RJ, Crompton GK. Sarcoidosis: a disorder commoner in non-smokers? Thorax 1986;41:787-791.
87. Hance AJ, Basset F, Saumon G, Danel C, Valeyre D, Battesti JP, Chretien J, Georges R. Smoking and interstitial lung disease: the effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann NY Acad Sci 1986;465:643-656.
88. Valeyre D, Soler P, Clerici C, Pré J, Battesti J-P, Georges R, Hance AJ. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 1988;43:516-524.
89. Murin S, Bilello KS, Matthay R. Other smoking-affected pulmonary diseases. Clin Chest Med 2000;21:121-137.
90. Kreiss K, Cox-Ganser J. Metalworking fluid-associated hypersensitivity pneumonitis: a workshop summary. Am J Ind Med 1997;32:423-432.
91. Warren C. Extrinsic allergic alveolitis: a disease commoner in nonsmokers. Thorax 1977;32:567-573.
92. Godfrey R. A national survey of bird fanciers' lung: including its possible association with jejunal villous atrophy [a report to the research committee of the British Thoracic Society]. Br J Dis Chest 1984;78:75-87.
93. Depierre A, Dalphin JC, Pernet D, Dubiez A, Faucompre C, Breton JL. Epidemiological study of farmer's lung in five districts of the French Doubs province. Thorax 1988;43:429-435.
94. Arima K, Ando M, Ito K, Sakata T, Yamaguchi T, Araki S, Futatsuka M. Effect of cigarette smoking on prevalence of summer-type hypersensitivity pneumonitis casued by Trichosporon cutaneum. Arch Environ Health 1992;47:274-278.
95. Sawyer RT, Day BJ, Fadok VA, Chiarappa-Zucca M, Maier LA, Fontenot AP, Silveira L, Newman LS. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease. Am J Respir Cell Mol Biol 2004;169:893-895.
96. Mattoli S, Kleimberg J, Stacey MA, Bellini A, Sun O, Marini M. The role of CD8+ Th2 lymphocytes in the development of smoking-related lung damage. Biochem Biophys Res Commun 1997;239:146-149.
97. Lim S, Roche N, Oliver BG, Mattos W, Barnes PJ, Fan Chung K. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10. Am J Respir Crit Care Med 2000;162:1355-1360.
98. Maier LA. Is smoking beneficial for granulomatous lung diseases? Am J Respir Crit Care Med 2004;169:893-895.
99. Blanchet MR, Israel-Assayag E, Cormier Y. Inhibitory effect of nicotine on experimental hypersensitivity pneumonitis in vivo and in vitro. Am J Respir Crit Care Med 2004;169:903-909.